skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 340  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Life Sciences & Biomedicine remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Material Type:
Article
Add to My Research

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

Gut, 2015-11, Vol.64 (11), p.1744-1754 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-307913 ;PMID: 25500202 ;CODEN: GUTTAK

Full text available

2
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Material Type:
Article
Add to My Research

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Nature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945

Full text available

3
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Material Type:
Article
Add to My Research

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

The Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]

Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470

Full text available

4
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Material Type:
Article
Add to My Research

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Diabetes care, 2021-06, Vol.44 (6), p.1433-1442 [Peer Reviewed Journal]

2021 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2151 ;PMID: 34016612

Full text available

5
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Material Type:
Article
Add to My Research

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

The American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609

Full text available

6
Natural Dietary and Herbal Products in Anti-Obesity Treatment
Material Type:
Article
Add to My Research

Natural Dietary and Herbal Products in Anti-Obesity Treatment

Molecules, 2016-10, Vol.21 (10), p.1351 [Peer Reviewed Journal]

Copyright MDPI AG 2016 ;2016 by the authors. 2016 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules21101351 ;PMID: 27727194

Full text available

7
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Material Type:
Article
Add to My Research

Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation

Diabetes (New York, N.Y.), 2016-08, Vol.65 (8), p.2282-2294 [Peer Reviewed Journal]

2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 1, 2016 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db16-0153 ;PMID: 27207552 ;CODEN: DIAEAZ

Full text available

8
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
Material Type:
Article
Add to My Research

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans

The American journal of clinical nutrition, 2020-08, Vol.112 (2), p.413-426 [Peer Reviewed Journal]

2020 American Society for Nutrition. ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. 2020 ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. ;Copyright American Society for Clinical Nutrition, Inc. Aug 2020 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/nqaa072 ;PMID: 32320006

Full text available

9
Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysis

Nutrition reviews, 2022-03, Vol.80 (4), p.838-856 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0029-6643 ;EISSN: 1753-4887 ;DOI: 10.1093/nutrit/nuab059 ;PMID: 34472619

Full text available

10
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study
Material Type:
Article
Add to My Research

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

Diabetologia, 2019-04, Vol.62 (4), p.665-675 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Diabetologia is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-018-4810-0 ;PMID: 30683945

Full text available

11
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
Material Type:
Article
Add to My Research

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

The New England journal of medicine, 2010-07, Vol.363 (3), p.245-256 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0909809 ;PMID: 20647200 ;CODEN: NEJMAG

Full text available

12
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes care, 2020-05, Vol.43 (5), p.1085-1093 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association May 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1745 ;PMID: 32139381

Full text available

13
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
Material Type:
Article
Add to My Research

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program

Diabetes care, 2022-10, Vol.45 (10), p.2396-2405 [Peer Reviewed Journal]

2022 by the American Diabetes Association. ;Copyright American Diabetes Association Oct 2022 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-1785 ;PMID: 35724304

Full text available

14
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Material Type:
Article
Add to My Research

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Diabetes care, 2013-12, Vol.36 (12), p.4022-4029 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Dec 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0234 ;PMID: 24144653 ;CODEN: DICAD2

Full text available

15
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Material Type:
Article
Add to My Research

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

The American journal of clinical nutrition, 2012-02, Vol.95 (2), p.297-308 [Peer Reviewed Journal]

2012 American Society for Nutrition. ;2015 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Feb 1, 2012 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.111.024927 ;PMID: 22158731 ;CODEN: AJCNAC

Full text available

16
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Material Type:
Article
Add to My Research

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2011-04, Vol.377 (9774), p.1341-1352 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 16-Apr 22, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60205-5 ;PMID: 21481449 ;CODEN: LANCAO

Full text available

17
The effects of oxytocin on eating behaviour and metabolism in humans
Material Type:
Article
Add to My Research

The effects of oxytocin on eating behaviour and metabolism in humans

Nature reviews. Endocrinology, 2017-12, Vol.13 (12), p.700-709 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2017 ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/nrendo.2017.115 ;PMID: 28960210

Full text available

18
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Material Type:
Article
Add to My Research

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

Obesity (Silver Spring, Md.), 2023-01, Vol.31 (1), p.111-122 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of The Obesity Society. ;2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society. ;Copyright Blackwell Publishing Ltd. Jan 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23621 ;PMID: 36502289

Full text available

19
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Material Type:
Article
Add to My Research

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Obesity (Silver Spring, Md.), 2022-04, Vol.30 (4), p.802-840 [Peer Reviewed Journal]

2022 The Obesity Society ;2022 The Obesity Society. ;Copyright Blackwell Publishing Ltd. Apr 2022 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23371 ;PMID: 35333446

Full text available

20
The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in‐person encounters
Material Type:
Article
Add to My Research

The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in‐person encounters

Obesity (Silver Spring, Md.), 2022-11, Vol.30 (11), p.2194-2203 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of The Obesity Society. ;2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society. ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23548 ;PMID: 36156456

Full text available

Results 1 - 20 of 340  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (318)

Refine My Results

Creation Date 

From To
  1. Before 2009  (14)
  2. 2009 To 2011  (65)
  3. 2012 To 2014  (55)
  4. 2015 To 2018  (86)
  5. After 2018  (121)
  6. More options open sub menu

Language 

  1. English  (338)
  2. Japanese  (49)
  3. Portuguese  (3)
  4. Spanish  (3)
  5. More options open sub menu

Searching Remote Databases, Please Wait